Healthcare Sales & Marketing Network News: GTI-2040

Searching News Database: GTI-2040

HSMN NewsFeed - 23 Jun 2008
Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for the treatment of Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 19 Jun 2007
Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Sep 2006
Lorus Therapeutics announces the appointment of a new President and Chief Executive Officer
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 12

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 12 additional stories matching:
GTI-2040
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!